Roland S. Annan

GSK1120212 (JTP-74057) Is an Inhibitor of MEK Activity and Activation with Favorable Pharmacokinetic Properties for Sustained <i>In Vivo</i> Pathway Inhibition

Aidan G. Gilmartin, Maureen R. Bleam, Arthur Groy et al. · Clinical Cancer Research · 2011 · 590 citations · Full text

Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL

Li Liu, James Greger, Hong Shi et al. · Cancer Research · 2009 · 471 citations · Full text

Phosphorylation of Sic1p by G ₁ Cdk Required for Its Degradation and Entry into S Phase

Rati Verma, Roland S. Annan, Michael J. Huddleston et al. · Science · 1997 · 449 citations

Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway

Priya Chaturvedi, Wai K Eng, Yuan Zhu et al. · Oncogene · 1999 · 423 citations

Chromatin, Genome Instability, Cell Regulation +8

Hydrophilic Interaction Chromatography Reduces the Complexity of the Phosphoproteome and Improves Global Phosphopeptide Isolation and Detection

Dean E. McNulty, Roland S. Annan · Molecular & Cellular Proteomics · 2008 · 343 citations · Full text